EA200601603A1 - Миметические антитела glp-1 человека, композиции, способы и применения - Google Patents
Миметические антитела glp-1 человека, композиции, способы и примененияInfo
- Publication number
- EA200601603A1 EA200601603A1 EA200601603A EA200601603A EA200601603A1 EA 200601603 A1 EA200601603 A1 EA 200601603A1 EA 200601603 A EA200601603 A EA 200601603A EA 200601603 A EA200601603 A EA 200601603A EA 200601603 A1 EA200601603 A1 EA 200601603A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- methods
- compositions
- mimetical
- antibodies
- human
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/605—Glucagons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Hospice & Palliative Care (AREA)
- Obesity (AREA)
- Plant Pathology (AREA)
- Emergency Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Настоящее изобретение относится по меньшей мере к одному новому миметическому антителу GLP-1 человека или его конкретной части или варианту, включая выделенные нуклеиновые кислоты, которые кодируют по меньшей мере одно миметическое антитело GLP-1 или его конкретную часть или вариант; миметическому антителу GLP-1 или его конкретной части или вариантам, векторам, клеткам-хозяевам, трансгенным животным или растениям и к способам их получения и применения, включая терапевтические композиции, способы и устройства.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US55798304P | 2004-03-31 | 2004-03-31 | |
US61298104P | 2004-09-24 | 2004-09-24 | |
PCT/US2005/010456 WO2005097175A2 (en) | 2004-03-31 | 2005-03-28 | Human glp-1 mimetibodies, compositions, methods and uses |
Publications (2)
Publication Number | Publication Date |
---|---|
EA200601603A1 true EA200601603A1 (ru) | 2007-08-31 |
EA011583B1 EA011583B1 (ru) | 2009-04-28 |
Family
ID=35125618
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200601603A EA011583B1 (ru) | 2004-03-31 | 2005-03-28 | Миметические антитела glp-1 человека, композиции, способы и применения |
EA200702093A EA200702093A1 (ru) | 2004-03-31 | 2005-12-22 | Антитела-миметики glp-1 человека, композиции, способы и их применение |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200702093A EA200702093A1 (ru) | 2004-03-31 | 2005-12-22 | Антитела-миметики glp-1 человека, композиции, способы и их применение |
Country Status (17)
Country | Link |
---|---|
US (1) | US20070135338A1 (ru) |
EP (1) | EP1750754A4 (ru) |
JP (1) | JP2008537873A (ru) |
KR (1) | KR20070004078A (ru) |
AR (1) | AR049014A1 (ru) |
AU (1) | AU2005231359A1 (ru) |
BR (1) | BRPI0509528A (ru) |
CA (1) | CA2563379A1 (ru) |
CR (1) | CR8706A (ru) |
EA (2) | EA011583B1 (ru) |
IL (1) | IL178432A0 (ru) |
MX (1) | MXPA06011425A (ru) |
NO (1) | NO20064953L (ru) |
SG (1) | SG151315A1 (ru) |
TW (1) | TW200602491A (ru) |
WO (1) | WO2005097175A2 (ru) |
ZA (1) | ZA200709266B (ru) |
Families Citing this family (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007081302A2 (en) * | 2005-03-28 | 2007-07-19 | Centocor, Inc. | Human glp-1 mimetibodies, compositions, methods and uses |
EP1906991A2 (en) * | 2004-06-28 | 2008-04-09 | Novo Nordisk A/S | Use of glp-1 receptor agonists and/or dpp-iv inhibitors in combination with proton pump inhibitors and ppar agonists for the preparation of a medicament for the treatment of diabetes type i, diabetes type ii and impaired pancreatic beta-cell function |
US7910101B2 (en) | 2004-10-25 | 2011-03-22 | Centocor, Inc. | Melanocortin receptor binding mimetibodies, compositions, methods and uses |
BRPI0518411A2 (pt) * | 2004-10-25 | 2008-11-18 | Centocor Inc | mimeticorpos que se ligam a receptor de melanocortina, composiÇÕes, mÉtodos e usos |
CN101415439A (zh) * | 2004-12-22 | 2009-04-22 | 森托科尔公司 | Glp-1激动剂、组合物、方法和用途 |
TW200643033A (en) * | 2005-03-08 | 2006-12-16 | Chugai Pharmaceutical Co Ltd | Conjugate of water-soluble modified hyaluronic acid and glp-1 analogue |
US11254748B2 (en) | 2005-04-15 | 2022-02-22 | Macrogenics, Inc. | Covalent diabodies and uses thereof |
US9963510B2 (en) | 2005-04-15 | 2018-05-08 | Macrogenics, Inc. | Covalent diabodies and uses thereof |
WO2010080538A1 (en) * | 2008-12-19 | 2010-07-15 | Macrogenics, Inc. | Covalent diabodies and uses thereof |
US9296816B2 (en) * | 2005-04-15 | 2016-03-29 | Macrogenics, Inc. | Covalent diabodies and uses thereof |
US9284375B2 (en) * | 2005-04-15 | 2016-03-15 | Macrogenics, Inc. | Covalent diabodies and uses thereof |
CN101273134B (zh) * | 2005-07-27 | 2012-01-04 | 王庆华 | 用于预防和治疗ⅰ型和ⅱ型糖尿病的组合物和方法 |
DE602005017628D1 (de) | 2005-09-22 | 2009-12-24 | Biocompatibles Uk Ltd | Fusionspolypeptide vom glp-1 (glucagon-like peptide-1) mit erhöhten peptidaseresistenz |
KR20080071134A (ko) * | 2005-10-24 | 2008-08-01 | 센토코 인코포레이티드 | Glp-2 모방체,폴리펩티드,조성물,방법 및 용도 |
EP1968645A4 (en) * | 2005-12-22 | 2009-11-04 | Centocor Ortho Biotech Inc | HUMAN GLP-1 MIMETIC BODIES AND COMPOSITIONS FOR THE TREATMENT OF ADIPOSITAS AND RELATED DISEASES, METHODS AND APPLICATIONS |
EP2007602A4 (en) * | 2006-03-31 | 2010-09-22 | Centocor Ortho Biotech Inc | HUMAN EPO MIMETICS IN HINGED CENTRAL REGION, COMPOSITIONS, METHODS AND USES IN THE PREVENTION OR TREATMENT OF GLUCOSE INTOLERANCE OR ANEMIA ASSOCIATED WITH NEPHROPATHY |
ATE444741T1 (de) | 2006-05-10 | 2009-10-15 | Biocompatibles Uk Ltd | Glp-1 peptide enthaltende kugelförmige mikrokapseln, deren produktion und deren verwendung |
AU2007275294A1 (en) * | 2006-07-18 | 2008-01-24 | Centocor, Inc. | Human GLP-1 mimetibodies, compositions, methods and uses |
WO2008028117A2 (en) * | 2006-08-31 | 2008-03-06 | Centocor, Inc. | Glp-2 mimetibodies, polypeptides, compositions, methods and uses |
TW200843794A (en) | 2006-12-21 | 2008-11-16 | Centocor Inc | Use of long-acting GLP-1 receptor agonists to improve insulin sensitivity and lipid profiles |
EP1975176A1 (en) * | 2007-03-27 | 2008-10-01 | Biocompatibles UK Limited | Novel glp-1 fusion peptides, their production and use |
CN101918027A (zh) * | 2007-11-02 | 2010-12-15 | 森托科尔奥索生物科技公司 | 半合成GLP-1肽-Fc融合构造、方法及其用途 |
KR101614494B1 (ko) | 2008-04-02 | 2016-04-22 | 마크로제닉스, 인크. | Bcr-복합체-특이적 항체 및 그것의 사용 방법 |
CA2726845C (en) * | 2008-06-04 | 2017-09-26 | Macrogenics, Inc. | Antibodies with altered binding to fcrn and methods of using same |
JP2011528709A (ja) * | 2008-07-21 | 2011-11-24 | トランスファーマ メディカル リミテッド | インクレチンおよびインクレチン模倣ペプチドの持続性送達用経皮システム |
ES2772731T3 (es) | 2008-10-17 | 2020-07-08 | Sanofi Aventis Deutschland | Combinación de una insulina y un agonista de GLP-1 |
CN102421420A (zh) * | 2009-05-13 | 2012-04-18 | 蛋白传输解决方案有限责任公司 | 用于跨膜递送的药物系统 |
US9096877B2 (en) | 2009-10-07 | 2015-08-04 | Macrogenics, Inc. | Fc region-containing polypeptides that exhibit improved effector function due to alterations of the extent of fucosylation, and methods for their use |
US8948863B2 (en) * | 2009-10-09 | 2015-02-03 | Board Of Regents, The University Of Texas System | Photokinetic ocular drug delivery methods and apparatus |
CA2778809C (en) | 2009-10-29 | 2020-08-04 | Janssen Biotech, Inc. | Antibody glycosylation variants |
EP2554183B1 (de) | 2009-11-13 | 2018-04-04 | Sanofi-Aventis Deutschland GmbH | Pharmazeutische Zusammensetzung umfassend einen GLP-1-Agonisten, ein Insulin und Methionin |
PE20121316A1 (es) | 2009-11-13 | 2012-10-05 | Sanofi Aventis Deutschland | Composicion farmaceutica que comprende un agonista de glp-1 y metionina |
HUE045487T2 (hu) | 2010-03-04 | 2019-12-30 | Macrogenics Inc | B7-H3-ra reaktív antitestek, immunológiailag aktív fragmenseik és alkalmazásaik |
US8802091B2 (en) | 2010-03-04 | 2014-08-12 | Macrogenics, Inc. | Antibodies reactive with B7-H3 and uses thereof |
AU2011202239C1 (en) | 2010-05-19 | 2017-03-16 | Sanofi | Long-acting formulations of insulins |
ES2667100T3 (es) | 2010-08-02 | 2018-05-09 | Macrogenics, Inc. | Diacuerpos covalentes y sus usos |
RU2546520C2 (ru) | 2010-08-30 | 2015-04-10 | Санофи-Авентис Дойчланд Гмбх | Применение ave0010 для производства лекарственного средства для лечения сахарного диабета 2 типа |
US9821032B2 (en) | 2011-05-13 | 2017-11-21 | Sanofi-Aventis Deutschland Gmbh | Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin |
AU2012259162C1 (en) | 2011-05-21 | 2020-05-21 | Macrogenics, Inc. | Deimmunized serum-binding domains and their use for extending serum half-life |
JP6367115B2 (ja) | 2011-08-29 | 2018-08-01 | サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | 2型糖尿病患者の血糖コントロールに使用する組合せ医薬 |
TWI559929B (en) | 2011-09-01 | 2016-12-01 | Sanofi Aventis Deutschland | Pharmaceutical composition for use in the treatment of a neurodegenerative disease |
EP2753642B8 (en) | 2011-09-06 | 2017-12-13 | Novo Nordisk A/S | Glp-1 derivatives |
US9487587B2 (en) | 2013-03-05 | 2016-11-08 | Macrogenics, Inc. | Bispecific molecules that are immunoreactive with immune effector cells of a companion animal that express an activating receptor and cells that express B7-H3 and uses thereof |
SG10201705245TA (en) | 2013-03-14 | 2017-07-28 | Macrogenics Inc | Bispecific Molecules That Are Immunoreactive With Immune Effector Cells That Express An Activating Receptor And An Antigen Expressed By A Cell Infected By A Virus And Uses Thereof |
SG11201506888VA (en) | 2013-04-03 | 2015-09-29 | Sanofi Sa | Treatment of diabetes mellitus by long-acting formulations of insulins |
UA116479C2 (uk) | 2013-08-09 | 2018-03-26 | Макродженікс, Інк. | БІСПЕЦИФІЧНЕ МОНОВАЛЕНТНЕ Fc-ДІАТІЛО, ЯКЕ ОДНОЧАСНО ЗВ'ЯЗУЄ CD32B I CD79b, ТА ЙОГО ЗАСТОСУВАННЯ |
US11384149B2 (en) | 2013-08-09 | 2022-07-12 | Macrogenics, Inc. | Bi-specific monovalent Fc diabodies that are capable of binding CD32B and CD79b and uses thereof |
CN104371019B (zh) * | 2013-08-13 | 2019-09-10 | 鸿运华宁(杭州)生物医药有限公司 | 一种能与glp-1r特异性结合的抗体及其与glp-1的融合蛋白质 |
EP2840091A1 (en) | 2013-08-23 | 2015-02-25 | MacroGenics, Inc. | Bi-specific diabodies that are capable of binding gpA33 and CD3 and uses thereof |
EP2839842A1 (en) | 2013-08-23 | 2015-02-25 | MacroGenics, Inc. | Bi-specific monovalent diabodies that are capable of binding CD123 and CD3 and uses thereof |
SG11201702544WA (en) | 2014-09-29 | 2017-04-27 | Univ Duke | Bispecific molecules comprising an hiv-1 envelope targeting arm |
ES2949095T3 (es) | 2014-12-12 | 2023-09-25 | Sanofi Aventis Deutschland | Formulación de relación fija de insulina glargina/lixisenatida |
TWI748945B (zh) | 2015-03-13 | 2021-12-11 | 德商賽諾菲阿凡提斯德意志有限公司 | 第2型糖尿病病患治療 |
TW201705975A (zh) | 2015-03-18 | 2017-02-16 | 賽諾菲阿凡提斯德意志有限公司 | 第2型糖尿病病患之治療 |
IL262396B2 (en) | 2016-04-15 | 2023-09-01 | Macrogenics Inc | New b7-h3 binding molecules, drug-antibody conjugates and their uses |
TWI829687B (zh) | 2018-05-07 | 2024-01-21 | 丹麥商諾佛 儂迪克股份有限公司 | 包含glp-1促效劑與n-(8-(2-羥基苯甲醯基)胺基)辛酸之鹽的固體組成物 |
EP4125829A4 (en) * | 2020-03-25 | 2024-07-24 | Massachusetts Gen Hospital | COMPOSITIONS AND METHODS FOR THE TREATMENT OF DIABETES |
Family Cites Families (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3773919A (en) * | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
US4309989A (en) * | 1976-02-09 | 1982-01-12 | The Curators Of The University Of Missouri | Topical application of medication by ultrasound with coupling agent |
FR2374910A1 (fr) * | 1976-10-23 | 1978-07-21 | Choay Sa | Preparation a base d'heparine, comprenant des liposomes, procede pour l'obtenir et medicaments contenant de telles preparations |
US5179017A (en) | 1980-02-25 | 1993-01-12 | The Trustees Of Columbia University In The City Of New York | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
US4399216A (en) | 1980-02-25 | 1983-08-16 | The Trustees Of Columbia University | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
US4634665A (en) * | 1980-02-25 | 1987-01-06 | The Trustees Of Columbia University In The City Of New York | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
US4656134A (en) * | 1982-01-11 | 1987-04-07 | Board Of Trustees Of Leland Stanford Jr. University | Gene amplification in eukaryotic cells |
US5149636A (en) * | 1982-03-15 | 1992-09-22 | Trustees Of Columbia University In The City Of New York | Method for introducing cloned, amplifiable genes into eucaryotic cells and for producing proteinaceous products |
US5168062A (en) * | 1985-01-30 | 1992-12-01 | University Of Iowa Research Foundation | Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence |
SE448277B (sv) | 1985-04-12 | 1987-02-09 | Draco Ab | Indikeringsanordning vid en doseringsanordning for lekemedel |
GB8601597D0 (en) * | 1986-01-23 | 1986-02-26 | Wilson R H | Nucleotide sequences |
SE453566B (sv) | 1986-03-07 | 1988-02-15 | Draco Ab | Anordning vid pulverinhalatorer |
US6849708B1 (en) * | 1986-05-05 | 2005-02-01 | The General Hospital Corporation | Insulinotropic hormone and uses thereof |
US4767402A (en) * | 1986-07-08 | 1988-08-30 | Massachusetts Institute Of Technology | Ultrasound enhancement of transdermal drug delivery |
EP0318512B1 (en) * | 1986-08-18 | 1998-06-17 | Emisphere Technologies, Inc. | Delivery systems for pharmacological agents |
US4946778A (en) * | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
DE3631229A1 (de) * | 1986-09-13 | 1988-03-24 | Basf Ag | Monoklonale antikoerper gegen humanen tumornekrosefaktor (tnf) und deren verwendung |
EP0279582A3 (en) * | 1987-02-17 | 1989-10-18 | Pharming B.V. | Dna sequences to target proteins to the mammary gland for efficient secretion |
US4873316A (en) * | 1987-06-23 | 1989-10-10 | Biogen, Inc. | Isolation of exogenous recombinant proteins from the milk of transgenic mammals |
US4956288A (en) | 1988-04-22 | 1990-09-11 | Biogen, Inc. | Method for producing cells containing stably integrated foreign DNA at a high copy number, the cells produced by this method, and the use of these cells to produce the polypeptides coded for by the foreign DNA |
US5225538A (en) * | 1989-02-23 | 1993-07-06 | Genentech, Inc. | Lymphocyte homing receptor/immunoglobulin fusion proteins |
US5116964A (en) * | 1989-02-23 | 1992-05-26 | Genentech, Inc. | Hybrid immunoglobulins |
US5266491A (en) | 1989-03-14 | 1993-11-30 | Mochida Pharmaceutical Co., Ltd. | DNA fragment and expression plasmid containing the DNA fragment |
US5580575A (en) * | 1989-12-22 | 1996-12-03 | Imarx Pharmaceutical Corp. | Therapeutic drug delivery systems |
US5404871A (en) | 1991-03-05 | 1995-04-11 | Aradigm | Delivery of aerosol medications for inspiration |
KR100246082B1 (ko) | 1991-07-02 | 2000-04-01 | 인헤일, 인코오포레이티드 | 에어로졸화된약제를전달하는방법및장치 |
FR2686899B1 (fr) * | 1992-01-31 | 1995-09-01 | Rhone Poulenc Rorer Sa | Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant. |
US5447851B1 (en) * | 1992-04-02 | 1999-07-06 | Univ Texas System Board Of | Dna encoding a chimeric polypeptide comprising the extracellular domain of tnf receptor fused to igg vectors and host cells |
WO1994006498A1 (en) | 1992-09-23 | 1994-03-31 | Fisons Plc | Inhalation device |
HU217917B (hu) | 1992-10-19 | 2000-05-28 | Dura Pharmaceuticals Inc. | Inhalálókészülék száraz porok inhalálásához |
US5643252A (en) * | 1992-10-28 | 1997-07-01 | Venisect, Inc. | Laser perforator |
US5849695A (en) * | 1993-01-13 | 1998-12-15 | The Regents Of The University Of California | Parathyroid hormone analogues useful for treatment of osteoporosis and disorders of calcium meatabolism in mammals |
AU5883694A (en) | 1993-01-19 | 1994-08-15 | Glaxo Group Limited | Device |
PL310327A1 (en) * | 1993-02-12 | 1995-12-11 | Univ Leland Stanford Junior | Adjustable transcription of target genes and other biological processes |
US5514670A (en) * | 1993-08-13 | 1996-05-07 | Pharmos Corporation | Submicron emulsions for delivery of peptides |
US5814599A (en) * | 1995-08-04 | 1998-09-29 | Massachusetts Insitiute Of Technology | Transdermal delivery of encapsulated drugs |
US5827690A (en) * | 1993-12-20 | 1998-10-27 | Genzyme Transgenics Corporatiion | Transgenic production of antibodies in milk |
WO1996036883A1 (en) * | 1995-05-17 | 1996-11-21 | Novo Nordisk A/S | Immunoassay for glucagon like protein 1 (glp-1) in plasma |
US5730723A (en) * | 1995-10-10 | 1998-03-24 | Visionary Medical Products Corporation, Inc. | Gas pressured needle-less injection device and method |
GB9526100D0 (en) | 1995-12-20 | 1996-02-21 | Intersurgical Ltd | Nebulizer |
NZ324374A (en) | 1996-01-03 | 1999-06-29 | Glaxo Group Ltd | Inhalation device |
UA65549C2 (ru) * | 1996-11-05 | 2004-04-15 | Елі Ліллі Енд Компані | Применение аналогов и производных glp-1 для периферического введения для борьбы с ожирением |
US5879681A (en) * | 1997-02-07 | 1999-03-09 | Emisphere Technolgies Inc. | Compounds and compositions for delivering active agents |
US5921447A (en) | 1997-02-13 | 1999-07-13 | Glaxo Wellcome Inc. | Flow-through metered aerosol dispensing apparatus and method of use thereof |
IL120943A (en) | 1997-05-29 | 2004-03-28 | Univ Ben Gurion | A system for administering drugs through the skin |
US6849719B2 (en) * | 1997-09-17 | 2005-02-01 | Human Genome Sciences, Inc. | Antibody to an IL-17 receptor like protein |
WO2000023591A2 (en) * | 1998-10-21 | 2000-04-27 | Zymogenetics, Inc. | Secreted protein zsig49 |
WO2000046380A2 (en) * | 1999-02-08 | 2000-08-10 | Chiron Corporation | Fibroblast growth factor receptor-immunoglobulin fusion |
CN1483041A (zh) * | 2000-12-07 | 2004-03-17 | Glp-1融合蛋白 | |
EP1494710A4 (en) * | 2002-03-26 | 2007-03-21 | Centocor Inc | DIABETES-RELEVANT IMMUNOGLOBULIN-BASED PROTEINS, COMPOSITIONS, PROCESSES AND USES |
EP1545608A4 (en) * | 2002-06-28 | 2006-09-13 | Centocor Inc | CH1-DELETED MAMMED MUICETIC BODIES, COMPOSITIONS, METHODS AND APPLICATIONS |
BR0312276A (pt) * | 2002-06-28 | 2005-04-26 | Centocor Inc | Mimeticorpos ch1-removidos miméticos de epo de mamìfero, composições, métodos e usos |
-
2005
- 2005-03-28 EP EP05730437A patent/EP1750754A4/en not_active Withdrawn
- 2005-03-28 AU AU2005231359A patent/AU2005231359A1/en not_active Abandoned
- 2005-03-28 BR BRPI0509528-0A patent/BRPI0509528A/pt not_active Application Discontinuation
- 2005-03-28 JP JP2007506454A patent/JP2008537873A/ja active Pending
- 2005-03-28 US US11/091,181 patent/US20070135338A1/en not_active Abandoned
- 2005-03-28 WO PCT/US2005/010456 patent/WO2005097175A2/en active Application Filing
- 2005-03-28 CA CA002563379A patent/CA2563379A1/en not_active Abandoned
- 2005-03-28 KR KR1020067022887A patent/KR20070004078A/ko not_active Application Discontinuation
- 2005-03-28 SG SG200902141-1A patent/SG151315A1/en unknown
- 2005-03-28 EA EA200601603A patent/EA011583B1/ru not_active IP Right Cessation
- 2005-03-28 MX MXPA06011425A patent/MXPA06011425A/es not_active Application Discontinuation
- 2005-03-30 TW TW094109910A patent/TW200602491A/zh unknown
- 2005-03-31 AR ARP050101276A patent/AR049014A1/es unknown
- 2005-12-22 EA EA200702093A patent/EA200702093A1/ru unknown
-
2006
- 2006-10-03 IL IL178432A patent/IL178432A0/en unknown
- 2006-10-25 CR CR8706A patent/CR8706A/es not_active Application Discontinuation
- 2006-10-30 NO NO20064953A patent/NO20064953L/no not_active Application Discontinuation
-
2007
- 2007-10-26 ZA ZA200709266A patent/ZA200709266B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
SG151315A1 (en) | 2009-04-30 |
AR049014A1 (es) | 2006-06-21 |
US20070135338A1 (en) | 2007-06-14 |
EP1750754A2 (en) | 2007-02-14 |
CR8706A (es) | 2009-01-16 |
KR20070004078A (ko) | 2007-01-05 |
AU2005231359A1 (en) | 2005-10-20 |
EP1750754A4 (en) | 2010-09-22 |
TW200602491A (en) | 2006-01-16 |
WO2005097175A3 (en) | 2009-11-19 |
WO2005097175A2 (en) | 2005-10-20 |
MXPA06011425A (es) | 2007-03-12 |
NO20064953L (no) | 2006-12-18 |
CA2563379A1 (en) | 2005-10-20 |
JP2008537873A (ja) | 2008-10-02 |
IL178432A0 (en) | 2007-02-11 |
EA200702093A1 (ru) | 2009-06-30 |
EA011583B1 (ru) | 2009-04-28 |
ZA200709266B (en) | 2009-05-27 |
BRPI0509528A (pt) | 2007-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200601603A1 (ru) | Миметические антитела glp-1 человека, композиции, способы и применения | |
EA200970131A1 (ru) | Миметические антитела для glp-1 человека, композиции, способы и применения | |
EA200501524A1 (ru) | Антитела против амилоида, композиции, способы и применения | |
EA200701362A1 (ru) | Агонисты glp-1, композиции, способы и применения | |
EA200702532A1 (ru) | Антитела против мср-1, композиции, способы и применения | |
CY1121353T1 (el) | Anti-tnf αντισωματα, συνθεσεις, μεθοδοi και χρησεις | |
CY1118901T1 (el) | Anti-il-12 αντισωματα, συνθεσεις, μεθοδοι και χρησεις | |
WO2006085961A3 (en) | Anti-mcp-1 antibodies, compositions, methods and uses | |
EA201070479A1 (ru) | Человеческие антиамилоидные антитела, композиции, способы и их применение | |
EA200600525A1 (ru) | Еро-имитирующие миметичекие антитела человека с центральной шарнирной областью, композиции, способы и применения | |
BRPI0921665A2 (pt) | humanizado anti-il-6 anticorpos | |
YU9403A (sh) | Anti-dualna antitela integrina, kompozicije, postupci i primene | |
CY1118880T1 (el) | Ανθρωπινα anti-il-23 αντισωματα, συνθεσεις, μεθοδοι και χρησεις | |
UA108066C2 (uk) | Білки, що зв'язуються з cgrp-рецепторами людини | |
EA200702374A1 (ru) | Анти-il-6 антитела, композиции, способы их получения и применения | |
WO2006124451A3 (en) | Anti-il-13 antibodies, compositions, methods and uses | |
TW200716745A (en) | Anti-TNF antibodies, compositions, methods and uses | |
TW200626173A (en) | IL-23p40 specific immunoglobulin derived proteins, compositions, epitopes, methods and uses | |
WO2004003147A3 (en) | Cngh0004 polypeptides, antibodies, compositions, methods and uses | |
TW200508246A (en) | Anti-dengue virus antibodies, compositions, methods and uses | |
WO2003057821A3 (en) | Mut-il-18 or mut-il-18r proteins, antibodies, compositions, methods and uses | |
WO2003102017A3 (en) | Anti-relp fusion antibodies, compositions, methods and uses | |
NO20075272L (no) | Humane GLP-1 "mimetibodies", sammensetninger, fremgangsmater og anvendelser | |
DK1740206T3 (da) | PHEP, en aminosyrepermease af Staphylococcus Aureus | |
WO2005067477A3 (en) | Anti-human lymphotoxin alpha antibodies, compositions, methods and uses |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM RU |